Skip to content

Research on the application of artificial intelligence network system based on deep learning to assist EUS in differentiating benign from malignant pancreatic mass lesions

Research on the application of artificial intelligence network system based on deep learning to assist EUS in differentiating benign from malignant pancreatic mass lesions

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036262
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic mass lesions

Interventions

Gold Standard:Pathological results
Index test:Accuracy&#32
of&#32
EUS&#32
in&#32
space-occupying&#32
lesions

Sponsors

The First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Ages 18-75, male or female are not limited; 2. No history of severe cardiopulmonary dysfunction, able to withstand anesthesia; 3. Subjects can understand the purpose of the trial, volunteer to participate and sign an informed consent form; 4. Subjects strongly request to identify the nature of the lesion through puncture; 5. EUS identified pancreatic cystic lesions with lesions larger than 1.5cm, intramural nodules, dilatation of the main pancreatic duct, increased CA199, abdominal pain, poor appetite, jaundice and other symptoms.

Exclusion criteria

Exclusion criteria: 1. Abnormal blood coagulation function (platelet count 1.5); 2. Oral anticoagulants were taken recently, and there were blood vessels in the puncture route; 3. Pregnant women, women preparing to become pregnant , or people with mental illness; 4. Patients with severe cardiopulmonary dysfunction who cannot tolerate anesthesia; 5. Patients with poor general conditions who cannot tolerate endoscopy examination or have endoscopic puncture contraindication, such as patients with postoperative reconstruction of the digestive tract, acute inflammation of the upper gastrointestinal tract, ulcers, stenosis and obstruction of the upper gastrointestinal tract, and endoscopy cannot pass through; 6. The lesion is close to large blood vessels, especially with aneurysms, with more intra-saccular separation, some lesions with intra-saccular hemorrhage, cyst rupture, and gastric cardia and gastric varices; 7. Subjects were equipped with implantable pacemakers, such as implantable automatic cardioverter defibrillator (AICD), nerve stimulator and cardiac pacemaker, and did not obtain the consent of the specialist in charge of the pacemaker to join the study; 8. Patients who are not expected to complete the EUS examination or EUS-FNA operation without signing the informed consent or other reasons.

Design outcomes

Primary

MeasureTime frame
Accuracy and sensitivity;

Countries

China

Contacts

Public ContactZhendong Jin

The First Affiliated Hospital of Naval Medical University

zhendongjin@163.com+86 13901618837

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026